SuRyon Shin

Dr. SuRyon Shin

Brigham and Women's Hospital (BWH) of Harvard Medical School, Boston, USA
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
XLXiaofei Li
Xiaofei Li
JZJing Zhao
Jing Zhao
VKVivek Kasinath
Vivek Kasinath
MUMayuko Uehara
Mayuko Uehara
LJLiwei Jiang
Liwei Jiang
RAReza Abdi
Reza Abdi
Although the immune response within draining lymph nodes (DLNs) has been studied for decades, how their stromal compartment contributes to this process remains to be fully explored. Here, we show that donor mast cells were prominent activators of collagen I deposition by fibroblastic reticular cells (FRCs) in DLNs shortly following transplantation. Serial analysis of the DLN indicated that the LN stroma did not return to its baseline microarchitecture following organ rejection and that the DLN contained significant fibrosis following repetitive organ transplants. Using several FRC conditional-knockout mice, we show that induction of senescence in the FRCs of the DLN resulted in massive production of collagen I and a proinflammatory milieu within the DLN. Stimulation of herpes virus entry mediator (HVEM) on FRCs by its ligand LIGHT contributed chiefly to the induction of senescence in FRCs and overproduction of collagen I. Systemic administration of ex vivo-expanded FRCs to mice decreased DLN fibrosis and strengthened the effect of anti-CD40L in prolonging heart allograft survival. These data demonstrate that the transformation of FRCs into proinflammatory myofibroblasts is critically important for the maintenance of a proinflammatory milieu within a fibrotic DLN.

15 April 2022 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
NWNiels G. A. Willemen
Niels G. A. Willemen
Shabir HassanShabir Hassan
Shabir Hassan
MGMelvin Gurian
Melvin Gurian
MJMaria Fernanda Jasso‐Salazar
Maria Fernanda Jasso‐Salazar
KFKai Fan
Kai Fan
SuRyon ShinSuRyon Shin
SuRyon Shin

21 June 2017 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
JLJuKyung Lee
JuKyung Lee
SuRyon ShinSuRyon Shin
SuRyon Shin
ADAnna Desalvo
Anna Desalvo
GLGeonhui Lee
Geonhui Lee
JLJeong Yoon Lee
Jeong Yoon Lee
HLHeaYeon Lee
HeaYeon Lee

20 January 2021 in Research Square
Verified
Preprint
Open access
PDF file
YJYasamin A. Jodat
Yasamin A. Jodat
TZTing Zhang
Ting Zhang
ZTZiad Al Tanoury
Ziad Al Tanoury
Tom KampermanTom Kamperman
Tom Kamperman
KSKun Shi
Kun Shi
SuRyon ShinSuRyon Shin
SuRyon Shin
Engineering of biomimetic tissue implants provides an opportunity for repairing volumetric muscle loss (VML), beyond a tissue’s innate repair capacity. Here, we present thick, suturable, and pre-vascularized 3D muscle implants containing human induced pluripotent stem cell-derived myogenic precursor cells (hiPSC-MPCs), which can differentiate into skeletal muscle cells while maintaining a self-renewing pool. The formation of contractile myotubes and millimeter-long fibers from hiPSC-MPCs is achieved in chemically, mechanically, and structurally tailored extracellular matrix-based hydrogels, which can serve as scaffolds to ultimately organize the linear fusion of myoblasts. Embedded multi-material bioprinting is used to deposit complex patterns of perfusable vasculatures and aligned hiPSC-MPC channels within an endomysium-like supporting gel to recapitulate muscle architectural integrity in a facile yet highly rapid manner. Moreover, we demonstrate successful graft-host integration and de novo muscle formation upon in vivo implantation of pre-vascularized constructs within a VML model. This work pioneers the engineering of large pre-vascularized hiPSC-derived muscle tissues toward next generation VML regenerative therapies.